Technological overview of iPS induction from human adult somatic cells.
about
Stem/Progenitor Cell Niches Involved in Hepatic and Biliary RegenerationValue of Organoids from Comparative Epithelia ModelsInduced pluripotent stem cells in hematology: current and future applicationsCell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's diseaseLong-term culture of genome-stable bipotent stem cells from adult human liverRapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue Engineering.Spot the difference: Solving the puzzle of hidden pictures in the lizard genome for identification of regeneration factorsGeneration of improved humanized mouse models for human infectious diseases.Recent technological updates and clinical applications of induced pluripotent stem cellsThe promise of perfect adult tissue repair and regeneration in mammals: Learning from regenerative amphibians and fish.A Comparative View on Human Somatic Cell Sources for iPSC GenerationPerinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone.Regenerative Medicine for the Aging Brain.Pluripotent stem cell energy metabolism: an updateGeneration of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells.Laser-assisted generation of human induced pluripotent stem cells.Comparison between the cultures of human induced pluripotent stem cells (hiPSCs) on feeder-and serum-free system (Matrigel matrix), MEF and HDF feeder cell lines.Effect of Induced Pluripotent Stem Cell Technology in Blood BankingCurrent Biosafety Considerations in Stem Cell Therapy.Human induced pluripotent stem cells from basic research to potential clinical applications in cancerIn vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model.Metabolic restructuring and cell fate conversion.The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy.Cell therapies for treatment of human immunodeficiency virus infection.Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.Bone-tissue engineering: complex tunable structural and biological responses to injury, drug delivery, and cell-based therapies.Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering.Human stem cell modeling in neurofibromatosis type 1 (NF1).Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Bone regeneration in the stem cell era: safe play for the patient?Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids.Systematic evaluation of markers used for the identification of human induced pluripotent stem cells.Simple derivation of transgene-free iPS cells by a dual recombinase approach.Isolation and Characterization of Human Adult Epithelial Stem Cells from the Periodontal Ligament.Synthetic mitochondria as therapeutics against systemic aging: a hypothesis.Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.Direct Reprogramming of Human Suspension Cells into Mesodermal Cell Lineages via Combined Magnetic Targeting and Photothermal Stimulation by Magnetic Graphene Oxide Complexes.Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside.Molecular mechanisms of induced pluripotency.
P2860
Q26765898-901D900D-D704-47AE-AD33-3F3904DFBB7FQ26775816-CC63C409-740A-4580-87AF-B3B5C6419304Q27016090-64A66093-31BF-42D7-B279-1689285C8EC4Q28080770-1D461847-F623-4D44-AADA-242D45FFE442Q28254408-2BF1C35B-A1E3-4246-B7DD-786248D89E62Q30804681-6B7C2BC3-9967-4BD5-9EA7-03CACF2AD86EQ33362699-A67B29C8-B71F-4186-9CB5-109DFCD975CDQ34135605-D372B636-6D04-4652-8DD8-9DA732D6988CQ34184553-DC0758F7-252F-418E-9D03-E76DF40BA8B3Q34429947-1EE70BEC-E064-4F74-9B4D-7F5A0DA0A656Q34560769-8D53AAC7-6E78-44E8-9365-6643CDE1B215Q34991991-74DC9AB9-FE17-4BF6-B9C3-D78F37D0F08FQ35089532-01FC5494-9919-4659-9C8A-A97FC2181DD6Q35109571-FACB3717-9F5B-4A36-8D26-B28DCFF84A52Q35162006-420DAF13-057A-47B2-A4AA-2D58DB052B41Q35389798-61174082-4B63-4B85-9CAE-3E2DC40EB230Q36087426-7B23B4A6-7EB6-474F-9A14-1D92034033C4Q36728573-F18F146B-B752-42A0-BAF4-63E57C8012B4Q37183239-FFB8AD03-9221-45A9-AB5B-5DF46EA9774BQ37316328-D46D1A9F-CE41-4D3F-897B-E1A0AA221D29Q37668698-841F1C0D-081B-4A92-A0E5-E4FA1FC51D0FQ38317505-576F399D-546C-4674-83C1-9FF28DC8EF96Q38349063-11827660-1DFA-4CBB-A215-FABA67FD7E67Q38366376-F9653B70-98C6-4222-A101-932B89F1BC44Q38372922-D7303AE8-9B5A-4350-95F0-C86B70C8816EQ38664383-CBC4CA13-82C4-464F-844D-F11CE822F64CQ38731982-77644306-F75E-4D37-91BA-292771CC64BBQ38732807-34509911-0FD6-432A-AF01-9469017E8C2DQ38803108-40E5D042-79EA-40DC-8C4D-85A63D4884A8Q38874111-B64DB28E-2CE3-4D43-BD2B-68A5DA4B12EAQ38941719-DFC44984-36A5-4969-84EE-683FB99D9D35Q41623746-30D54AD1-6DA3-494F-BEF8-CA69791A71A5Q42175649-B45B04BF-4432-43FA-93F2-229EE9CCA5ADQ42228486-DFC754D9-BCC7-4368-BCE2-2698AD5B62F4Q46279915-5B228B85-4738-4F41-A740-6D500B4A0282Q46844137-D56A817C-E2B9-453B-9ECE-F52CA4D9DD5AQ47688118-D714B027-B11D-48CE-804D-8D97838F0F63Q47970651-82EE1D1A-0B7A-4AFE-8FF0-6F86E03A6C73Q48343541-3D7DCBEF-51AF-4713-B46B-F5B8B641A69DQ52966119-0EDDBFC0-F894-4ADB-A5ED-FE2904781EDD
P2860
Technological overview of iPS induction from human adult somatic cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Technological overview of iPS induction from human adult somatic cells.
@en
type
label
Technological overview of iPS induction from human adult somatic cells.
@en
prefLabel
Technological overview of iPS induction from human adult somatic cells.
@en
P2860
P1433
P1476
Technological overview of iPS induction from human adult somatic cells.
@en
P2093
Emilie Bayart
Odile Cohen-Haguenauer
P2860
P356
10.2174/1566523211313020002
P407
P577
2013-04-01T00:00:00Z